Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03012
Species: Homo sapiens
Position : chr19:15311000-15312500
Year: 2020
Title: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  33219226
MONDO: MONDO:0005061
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: H2023
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Functional perturbation assay; TF binding assay
High Throughput Method: NRF2 ChIP-seq; H3K27ac ChIP-seq; RNA-seq
Low Throughput Method: NRF2 knockdown; ChIP-qPCR; RT-qPCR
About Target Gene
Target gene : NOTCH3
About TF
TF name : NFE2L2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
NFE2L2 Protein processing in endoplasmic reticulum kegg 166
NFE2L2 Hs_Photodynamic_therapy-induced_unfolded_protein_response_WP3613_89330 wikipathways 6
NFE2L2 Hs_Transcriptional_activation_by_NRF2_WP3_79527 wikipathways 6
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_02954 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02955 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02956 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02957 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02958 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02959 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
Expression of Target Genes for the Enhancer